Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review

A Jamieson; AM Goodwill; M Termine; S Campbell; C Szoeke

Journal article

Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review

A Jamieson, AM Goodwill, M Termine, S Campbell, C Szoeke

Journal of Affective Disorders | ELSEVIER | Published : 2019

DOI: 10.1016/j.jad.2019.03.042

Abstract

Background: Depression's relationship with cerebral abnormalities and cognitive decline is temporally dynamic. Despite clear clinical utility, understanding depression's effect on cerebral structures, cognitive impairment and the interaction between these symptoms has had limited consideration. Methods: This review summarised studies examining a clinical depression diagnosis or validated scales measuring depressive symptoms, data concerning amyloid-beta (Aβ) levels, brain structure and function focusing on hippocampal alterations, or white matter hyperintensities (WMH), and at least one validated neuropsychological test. Online database searches of: PsycINFO, EMBASE, MEDLINE, and Scopus were..

View full abstract

University of Melbourne Researchers

Cassandra Szoeke Author

Alec Jamieson Author

Related Projects (3)

MODIFIABLE RISK FACTORS FOR COGNITIVE IMPAIRMENT IN AGEING

This study focuses on age-related decline in cognitive function in midlife.Early detection of people at risk will allow the introduction of ..

WOMEN'S HEALTHY AGEING COGNITIVE PROJECT

The changes of Alzheimer’s disease occur a decade prior to symptoms. Therefore we need longitudinal prospective data over 20 years to determ..

THE ASSOCIATIONS BETWEEN COGNITIVE DECLINE AND GENETIC POLYMORPHISMS, HORMONES AND CARDIOVQSCULAR RISK FACTORS IN WOMEN

Dementia, a major cause of morbidity and mortality in ageing women, has been linked to hormonal changes and genes. If factors associated wit..

Grants

Awarded by Alzheimer's Association

Funding Acknowledgements

Funding for the Healthy Ageing Program (HAP) has been provided by the National Health and Medical Research Council (NHMRC Grants 547600, 1032350 & 1062133), Ramaciotti Foundation, Australian Healthy Ageing Organisation, the Brain Foundation, the Alzheimer's Association (NIA320312), Australian Menopausal Society, Bayer Healthcare, Shepherd Foundation, Scobie and Claire Mackinnon Foundation, Collier Trust Fund, J.O. & J.R. Wicking Trust, Mason Foundation and the Alzheimer's Association of Australia. Inaugural funding was provided by VicHealth and the NHMRC. The Principal Investigator of HAP (Cassandra Szoeke) is supported by the National Health and Medical Research Council (NHMRC Grants 547600, 1032350 and 1062133.